Effect of Magnesium Sulfate on the control of bleeding during Lumbar Spinal Fusion Surgery

Phase 3

Recruiting

• Conditions: umbar Spinal Fusion Surgery.; Fusion of spine, lumbar region; M43.26

• Registration Number: IRCT20200825048515N15
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients who are candidates for lumbar spinal fusion surgery
Aged between 20 and 60 years
ASA I and II based on America Society of Anesthesiologists (ASA) classification
Being consent to participate in the study

Exclusion Criteria

Allergy to magnesium sulfate
Liver, kidney, cardiovascular failure
Opioid use
Consumption of NSAIDs
Consumption of calcium channel blockers

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Systolic blood pressure. Timepoint: Before surgery, immediately after surgery and 15, 30, 45, and 60 minutes during surgery and in recovery. Method of measurement: Monitoring device.;Diastolic blood pressure. Timepoint: Before surgery, immediately after surgery and 15, 30, 45 and 60 minutes during surgery and in recovery. Method of measurement: Monitoring device.;Hear rate. Timepoint: Before surgery, immediately after surgery and 15, 30, 45 and 60 minutes during surgery and in recovery. Method of measurement: Monitoring device.;Amount of bleeding. Timepoint: During surgery and in recovery. Method of measurement: Blood in suction and gauze.